Vanrenterghem, Yves
Universitair Ziekenhuis Leuven
3 papers on CoChat
Most cited papers
- Verified
Belatacept-based regimens are associated with improved cardiovascular and metabolic risk factors compared with cyclosporine in kidney transplant recipients (BENEFIT and BENEFIT-EXT studies)
Vanrenterghem, Y., Bresnahan, B., Campistol, J., Durrbach, A., Grinyó, J., Neumayer, H.-H., Lang, P., Larsen, C. P., Mancilla-Urrea, E., Pestana, J. M., et al. (2011) · Transplantation
Renal Transplantation Outcomes and TreatmentsTransplantation: Methods and Outcomes
Cited by 183
- Verified
Effect of different immunosuppressive regimens on the evolution of distinct metabolic parameters: Evidence from the symphony study
Claes, K., Meier-Kriesche, H.-U., Schold, J. D., Vanrenterghem, Y., Halloran, P. F., & Ekberg, H. (2012) · Nephrology Dialysis Transplantation
Renal Transplantation Outcomes and TreatmentsTransplantation: Methods and Outcomes
Cited by 75
- Verified
Fundus changes in membranoproliferative glomerulonephritis type II: A fluorescein angiographic study of 23 patients
Leys, A., Vanrenterghem, Y., Van Damme, B., Snyers, B., Pirson, Y., & Leys, M. (1991) · Graefe s Archive for Clinical and Experimental Ophthalmology
Renal Diseases and GlomerulopathiesRetinal Diseases and Treatments
Cited by 57
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free